Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.81, $0.01 better than the analyst estimate of $1.80. Revenue for the quarter came in at $1.92 billion versus the consensus estimate of $1.96 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2021 EPS of $7.32-$7.47, versus the consensus of $7.70.

• 2021 reported revenue growth 11.3% - 12.5%

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.